XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Convertible Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings (Accumulated Deficit)
Balance at Dec. 31, 2019 $ 1,480,158 $ 20,801   $ 1,720,129 $ (18,854) $ (241,918)
Balance, Shares at Dec. 31, 2019   166,410,000 0      
Net issuance of common stock under stock-based plans 4,850 $ 154   4,696    
Net issuance of common stock under stock-based plans (in shares)   1,230,000        
Stock-based compensation expense 44,285     44,285    
Repurchase of common stock (88,465) $ (190)       (88,275)
Repurchase of common stock (in shares)   (1,517,000)        
Cash dividends (66,540)         (66,540)
Convertible common shares (3,787)     (3,787)    
Convertible common shares (in shares)     3,787,000      
Net income 784,147         784,147
Other comprehensive income/loss 52,370       52,370  
Balance at Dec. 31, 2020 2,207,018 $ 20,765   1,765,323 33,516 387,414
Balance, Shares at Dec. 31, 2020   166,123,000 3,787,000      
Net issuance of common stock under stock-based plans   $ 113   (225) (112)  
Net issuance of common stock under stock-based plans (in shares)   899,000        
Stock-based compensation expense 45,632     45,632    
Repurchase of common stock (600,000) $ (597)       (599,403)
Repurchase of common stock (in shares)   (4,771,000)        
Cash dividends (66,034)         (66,034)
Convertible common shares 2,275     2,275    
Convertible common shares (in shares)     (2,275,000)      
Settlements of convertible notes 985,640 $ 1,018   984,622    
Settlement of convertible notes (in shares)   8,148,000        
Exercise of convertible notes hedge call options (987,100) $ (1,018)   (986,082)    
Exercise of convertible notes hedge call options (in shares)   (8,148,000)        
Net income 1,014,589         1,014,589
Other comprehensive income/loss (39,464)       (39,464)  
Balance at Dec. 31, 2021 2,562,444 $ 20,281   1,811,545 (5,948) 736,566
Balance, Shares at Dec. 31, 2021   162,251,000 1,512,000      
Net issuance of common stock under stock-based plans (4,375) $ 96   (4,471)    
Net issuance of common stock under stock-based plans (in shares)   761,000        
Stock-based compensation expense 48,466     48,466    
Repurchase of common stock (752,082) $ (907)       (751,175)
Repurchase of common stock (in shares)   (7,253,000)        
Cash dividends (69,763)         (69,763)
Convertible common shares 1,512     1,512    
Convertible common shares (in shares)     (1,512,000)      
Settlements of convertible notes (255) $ 187   (442)    
Settlement of convertible notes (in shares)   1,495,000        
Exercise of convertible notes hedge call options   $ (187)   187    
Exercise of convertible notes hedge call options (in shares)   (1,495,000)        
Cumulative effect of change in accounting principle related to convertible debt (6,234)     (100,834)   94,600
Net income 715,501         715,501
Other comprehensive income/loss (43,920)       (43,920)  
Balance at Dec. 31, 2022 $ 2,451,294 $ 19,470   $ 1,755,963 $ (49,868) $ 725,729
Balance, Shares at Dec. 31, 2022   155,759,000 0